BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35701686)

  • 1. Evaluation of Different Doses of the Aromatase Inhibitor Letrozole for the Treatment of Ectopic Pregnancy and Its Effect on Villous Trophoblastic Tissue.
    Alabiad MA; Said WMM; Gad AH; Sharaf ElDin MTA; Khairy DA; Gobran MA; Shalaby AM; Samy W; Abdelsameea AA; Heraiz AI
    Reprod Sci; 2022 Oct; 29(10):2983-2994. PubMed ID: 35701686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Aromatase Inhibitor Letrozole on the Placenta of Adult Albino Rats: A Histopathological, Immunohistochemical, and Biochemical Study.
    Alabiad MA; Elhasadi I; Alnasser SM; Alorini M; Alshaikh ABA; Jaber FA; Shalaby AM; Samy W; Heraiz AI; Mohammed Albakoush KM; Khairy DA
    Iran J Med Sci; 2024 Jan; 49(1):46-56. PubMed ID: 38322160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of letrozole with misoprostol for medical termination of pregnancy on the expression of steroid receptors in the placenta.
    Lee VC; Gao J; Lee KF; Ng EH; Yeung WS; Ho PC
    Hum Reprod; 2013 Nov; 28(11):2912-9. PubMed ID: 23980056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental villous vascular endothelial growth factor expression and vascularization after estrogen suppression during the last two-thirds of baboon pregnancy.
    Robb VA; Pepe GJ; Albrecht ED
    Endocrine; 2007 Jun; 31(3):260-7. PubMed ID: 17906373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibitor letrozole: a novel treatment for ectopic pregnancy.
    Mitwally MF; Hozayen WG; Hassanin KMA; Abdalla KA; Abdalla NK
    Fertil Steril; 2020 Aug; 114(2):361-366. PubMed ID: 32622660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 7 days of letrozole pretreatment combined with misoprostol on the expression of progesterone receptor and apoptotic factors of placental and decidual tissues from first-trimester abortion: a randomized controlled trial.
    Yung SSF; Lee VCY; Chiu PCN; Li HWR; Ng EHY; Yeung WSB; Ho PC
    Contraception; 2016 Apr; 93(4):323-330. PubMed ID: 26707996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.
    Mai Q; Hu X; Yang G; Luo Y; Huang K; Yuan Y; Zhou C
    Am J Obstet Gynecol; 2017 Jan; 216(1):42.e1-42.e10. PubMed ID: 27555316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.
    Begum MR; Ferdous J; Begum A; Quadir E
    Fertil Steril; 2009 Sep; 92(3):853-857. PubMed ID: 18177867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment.
    Takagi K; Ishida T; Miki Y; Hirakawa H; Kakugawa Y; Amano G; Ebata A; Mori N; Nakamura Y; Watanabe M; Amari M; Ohuchi N; Sasano H; Suzuki T
    Br J Cancer; 2013 Jul; 109(1):100-8. PubMed ID: 23756858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome.
    Casper RF; Mitwally MF
    Clin Obstet Gynecol; 2011 Dec; 54(4):685-95. PubMed ID: 22031258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
    Franik S; Kremer JA; Nelen WL; Farquhar C
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010287. PubMed ID: 24563180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effects of letrozole.
    Miller WR; Anderson TJ; Dixon JM
    Cancer Invest; 2002; 20 Suppl 2():15-21. PubMed ID: 12442345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.
    George S; Feng Y; Manola J; Nucci MR; Butrynski JE; Morgan JA; Ramaiya N; Quek R; Penson RT; Wagner AJ; Harmon D; Demetri GD; Krasner C
    Cancer; 2014 Mar; 120(5):738-43. PubMed ID: 24222211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle.
    Haas J; Bassil R; Gonen N; Meriano J; Jurisicova A; Casper RF
    Reprod Biol Endocrinol; 2018 May; 16(1):54. PubMed ID: 29843716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.
    Franik S; Eltrop SM; Kremer JA; Kiesel L; Farquhar C
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010287. PubMed ID: 29797697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.
    Lykkesfeldt AE; Henriksen KL; Rasmussen BB; Sasano H; Evans DB; Møller S; Ejlertsen B; Mouridsen HT
    BMC Cancer; 2009 Jun; 9():185. PubMed ID: 19531212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice.
    Hirakawa H; Yokoyama Y; Yoshida H; Mizunuma H
    J Ovarian Res; 2014 Jan; 7():4. PubMed ID: 24410765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphen citrate gonadotropins in controlled ovarian hyperstimulation: a prospective, simply randomized, clinical trial.
    Sh Tehrani Nejad E; Abediasl Z; Rashidi BH; Azimi Nekoo E; Shariat M; Amirchaghmaghi E
    J Assist Reprod Genet; 2008 May; 25(5):187-90. PubMed ID: 18427974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue.
    Fang Z; Yang S; Gurates B; Tamura M; Simpson E; Evans D; Bulun SE
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3460-6. PubMed ID: 12107266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.